Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
Status:
Completed
Trial end date:
2018-10-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of mesenchymal stromal cells (MSCs)
obtained from umbilical cords for the treatment of adults with active systemic lupus
erythematosus (SLE).